Navigation Links
New Chemical May Halt HIV Infection

Infection from the Human Immunodeficiency Virus (HIV) can be blocked by a chemical called CSA-54, according to US based scientists. The disease is reportedly responsible for 25 million deaths across the world since 1981. //The lab tests of the chemical CSA-54 found that it disables the virus's ability to infect cells, according to BBC News.

The tests were carried out by researcher Derya Unutmaz, Associate Professor of Microbiology and Immunology at the Vanderbilt University School of Medicine, and his team. HIV specifically targets a type of immune cell called CD4+. The lab tests showed that CSA-54 blocked infection by disrupting HIV's ability to interact with the cells. The compound is expected to be equally effective against all the strains of the HIV virus.

The chemical was developed by the scientists at Brigham Young University, Utah, and is licensed to a company called Ceragenix Pharmaceuticals. Brigham Young University and Vanderbilt have jointly filed a patent on the compounds. The research is still at its early stages, and many years may pass before clinical trials are conducted.

Edited (IANS)
'"/>




Page: 1

Related medicine news :

1. Chemical in Gila monsters saliva yields Alzheimer drug
2. Chemical found in plants may be the treatment for leukemia
3. Chemicals in clear plastics can cause learning difficulties
4. Quitting Smoking Made Easy By Track Of New Chemical
5. Brain Chemical Identified For Drug Dependent Behavior
6. Block Immune System Chemical For Treating Asthma
7. Chest Pain Can Be Identified By New Tracer Chemical 30 Hours After Pain Relief
8. Chemical Signaling Helps Regulate Sensory Map Formation In The Brain
9. High Levels Of Cancer Chemical Found In Soft Drinks
10. Sedatives Derived From Chemicals Can Make Elderly Nervous
11. Chemicals causing Cancer Found In Soft Drinks In UK
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Chemical May Halt HIV Infection

(Date:7/8/2008)...following statement was issued,today by the law fi...otice is hereby given that a class action lawsuit ...the Middle District of Tennessee on behalf,of all ...q: HWAY ),("Healthways" or the "Company") from Oc...e (the "Class Period")., If you wish to discuss t...
(Date:7/8/2008)...elays in Oxygen Orders, Lack of,Trained Technician... -- The new Medicare,competitive bidding program f...nd chaos for beneficiaries, physicians, hospital d...viders across the country since it,was implemented... program has triggered widespread disruptions in s...
(Date:7/8/2008)...ociety of Hematology (ASH) is proud to announce th... Pathway Grant. The grant is given to training pro...plementation of novel hematology-related training ...sity, Donald Mahoney Jr., MD, of Baylor College of...Sinai School of Medicine, will each receive the gr...
(Date:7/8/2008)...os Innovation,s Proprietary,Device-Free Remote Mo... and Medical Costs, N...ovations, a pioneer,in assisting clients to achiev...ce improvement through a device-free remote monito...e Iowa Medicaid Congestive Heart Failure,Populatio...
Breaking Medicine News(10 mins):Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...test developed by a team led by a University of Le...rnment’s Independent Depleted Uranium// Oversight ...uranium (DU) during the 1991 Gulf Conflict. Ra...ology, developed the test with Postdoctoral Fellow...
...udying the genetic make-up using blood samples to ...g treatment, has been in practice//. Now, scientis...thods based on such existing tests that might reve...come victims of substance abuse or suffer antisoci...
...University of Iowa study has revealed that it may ...ions like panic disorder with blood tests//. This ...information in immature white blood cells. "The ...quantum leap in psychiatry," said the study's lead...
...searchers in the United States have developed a me...ll four types of the dengue// virus. The dengue v...cephalitis. The four types of virus are all suffic...iduals vaccinated against one virus type are still...
Other Medicine News:Health News:DU Test Finds UK Troops Uranium Free 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 3Health News:Mental Health Conditions Could Be Detected With Blood Tests 2
(Date:7/7/2008)...- Light Sciences Oncology, Inc.,(LSO) today announ...enign,prostatic hyperplasia (BPH), or enlargement ...(Litx(TM)), an innovative light-activated drug,tre...2-patient, Phase I/II,dose-escalation study at fou...nt, Phase IIa study in Australia, expected to begi...
(Date:7/7/2008)...irstCall/ -- Biopure Corporation,(Nasdaq: BPUR ) ...he Food,and Drug Administration (FDA) on identifyi...ical trial of Hemopure(R) [hemoglobin glutamer -,2... study use of Hemopure,in patients suffering from ...usion with blood components. Currently, AML patien...
(Date:7/6/2008)...horization Application currently ...- Cell Therapeutics, Inc. (...lication of results from its,randomized phase III ...,CT-2103) with gemcitabine or vinorelbine for the ...with previously untreated non-small cell,lung canc...
(Date:7/3/2008)...sachusetts, July 3,/-, -...ny, Jerini AG for an equity purchase price of EUR...oduct, FIRAZYR(R), to its Human Genetic Therapies ...es expected to be around $350-400 million, based ...ent, - Expected to be accretive for Non GAAP earn...
Breaking Medicine Technology:Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 2Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 3Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 1Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 2Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 3Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 4Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 1Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 2Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 3Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 4Syngenta Licenses Chromatin Gene Stacking Technology 1373 1Syngenta Licenses Chromatin Gene Stacking Technology 1373 2Research approved for Hawaiian military training area 888 1Research approved for Hawaiian military training area 888 2
...nt Plans - , ,OTTAWA, Canada – March 7, 2007...al company specializing in developing,advanced pro...ften,called “good cholesterol,” today ... of its lead product, CRD5. CRD5 is,being develope...ase. , ,Results showed, to date, that CRD5 was saf...
... 12, 2007 - Ceragenix Pharmaceuticals,Inc. (OTCBB...ectious disease and dermatology, today announced t...emonstrated virtually no biofilm,formation in a 21...treated with Ceragenins,were soaked daily in a pho...atheter. At day 21, the catheters were challenged ...
Other Medicine Technology:Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 2Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 3Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3
...igation system for ENT, cranial and spine procedur...y, critical zones visible during tracking. Image f...n freezes image, snapshot can be taken of frozen i...the microscope, low profile receiver attachment. A...
The spinal system neon is a modular system for posterior stabilization. Its application range extends from occipitocervical via cervical to cervicothoracic applications. In the case of children, it c
Bacon Cranial Rongeur
Cushing Pituitary Rongeur
Medicine Products: